(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

CONJUGADOS DE ANTICORPO-FÁRMACO IMUNOMODULATÓRIOS

ArquivadaInvention PatentPCT · US2022012599

Application data

Number

112023014128

Type

Invention Patent

Filing

01/14/2022

Publication

10/31/2023

PCT

US2022012599

Progress at the INPI

  1. Filing01/14/22
  2. Publication10/31/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 01/14/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/08/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SEAGEN INC.

US

See this company's full portfolio

Inventors

A. H. (pessoa física)

US

E. G. (pessoa física)

US

E. C. (pessoa física)

US

P. B. (pessoa física)

US

S. G. (pessoa física)

US

Technical data

Priority claims

US

63/138,360 · 01/15/2021

US

63/292,779 · 12/22/2021

Abstract

CONJUGADOS DE ANTICORPO-FÁRMACO IMUNOMODULATÓRIOS. A presente divulgação fornece, inter alia, conjugados de anticorpo-fármaco que são úteis no tratamento de várias doenças, como o câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

04/08/2025

RPI 2831

Arquivamento - Art. 33 da LPI

#11.1

01/21/2025

RPI 2820

Notificação de entrada na fase nacional - PCT

#1.3

10/31/2023

RPI 2756

Alteração de dados cadastrais

#1.1

07/25/2023

RPI 2742

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.